How significant are these to SDB business and GMV med-devices? Beds:
They have a combined >6000 beds for in-patents and surgeries.
vs
Royal Melbourne Hospital has only 570 beds.
How many patients:
They treat >10 million out-pateints in a year, approx the combined population of Sydney/4m, Melbourne/4.5m, Brisbane/2m
How many Primza sensors will they need in future?
Subsequent to singing 16/11/17 MOU with GMV , UGHL has moved aggresively expanded into *Aged-care and *Home-care businesses in China, Japan, Thailand. https://www.otcmarkets.com/stock/UGHL/news
Note:
1.HKSE pre revenue biotech IPO
"To qualify for a Hong Kong listing, biotech candidates must have
a market valuation of at least HK$1.5 billion (US$191.13 million) at the time of listing, one “sophisticated” pre-IPO investor,
a product that has passed a phase one clinical trial primarily aimed at showing its safety, and has regulatory approval to begin phase two to prove its efficacy."